DPP-4 Inhibitors in the Prevention/Treatment of Pulmonary Fibrosis, Heart and Kidney Injury Caused by COVID-19—A Therapeutic Approach of Choice in Type 2 Diabetic Patients?

Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China

(2020) Dawei Wang et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury

(2020) Clark D Russell et al.   LANCET

Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study

(2020) Heshui Shi et al.   LANCET INFECTIOUS DISEASES

A pneumonia outbreak associated with a new coronavirus of probable bat origin

(2020) Peng Zhou et al.   NATURE

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

(2020) Michael Letko et al.   Nature Microbiology

Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication

(2020) Yuchen Chen et al.   DIABETES CARE

Exposure to DPP ‐4 inhibitors and COVID ‐19 among people with type 2 diabetes. A case–control study

(2020) Gian Paolo Fadini et al.   DIABETES OBESITY & METABOLISM

COVID-19 and diabetes: Can DPP4 inhibition play a role?

(2020) Gianluca Iacobellis   DIABETES RESEARCH AND CLINICAL PRACTICE

Letter to the editor in response to the article “COVID-19 and diabetes: Can DPP4 inhibition play a role?”

(2020) Visnja Kokic Males   DIABETES RESEARCH AND CLINICAL PRACTICE

DPP4 inhibition: preventing SARS‐CoV ‐2 infection and/or progression of COVID ‐19?

(2020) Rocky Strollo et al.   DIABETES-METABOLISM RESEARCH AND REVIEWS

Coronavirus Infections and Type 2 Diabetes—Shared Pathways with Therapeutic Implications

(2020) Daniel J Drucker   ENDOCRINE REVIEWS

Role of Dipeptidyl Peptidase 4 Inhibitors in Diabetic Patients with Coronavirus-19 Infection

(2020) Chun-Fan Chen et al.   Journal of the Chinese Medical Association

Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?

(2020) Andrew I Ritchie et al.   LANCET

Diabetes and COVID-19

(2020) Béatrice Bouhanick et al.   THERAPIE

COVID‐19 and comorbidities: A role for dipeptidyl peptidase 4 ( DPP4 ) in disease severity?

(2020) Margaret F. Bassendine et al.   Journal of Diabetes

Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?

(2020) Lei Fang et al.   Lancet Respiratory Medicine

Potential Effects of Coronaviruses on the Cardiovascular System

(2020) Mohammad Madjid et al.   JAMA Cardiology

Is DPP4 inhibition a comrade or adversary in COVID-19 infection

(2020) Rinkoo Dalan   DIABETES RESEARCH AND CLINICAL PRACTICE

Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes

(2019) Carolyn F. Deacon   Frontiers in Endocrinology

Editorial: Multi-Target-Directed Ligands (MTDL) as Challenging Research Tools in Drug Discovery: From Design to Pharmacological Evaluation

(2019) Stefano Alcaro et al.   Frontiers in Chemistry

DPP-4 inhibition: А novel therapeutic approach to the treatment of pulmonary hypertension?

(2019) Marko Anderluh et al.   PHARMACOLOGY & THERAPEUTICS

Quality of life reported by survivors after hospitalization for Middle East respiratory syndrome (MERS)

(2019) Sarah Batawi et al.   Health and Quality of Life Outcomes

Dipeptidyl peptidase IV (DPP-4) inhibition alleviates pulmonary arterial remodeling in experimental pulmonary hypertension

(2018) Jian Xu et al.   LABORATORY INVESTIGATION

Mechanisms and pathways of anti-inflammatory activity of DPP-4 inhibitors in cardiovascular and renal protection

(2018) Katarina Tomovic et al.   MEDICINAL RESEARCH REVIEWS

Cross-talk between the dipeptidyl peptidase-4 and stromal cell-derived factor-1 in stem cell homing and myocardial repair: Potential impact of dipeptidyl peptidase-4 inhibitors

(2016) Marko Anderluh et al.   PHARMACOLOGY & THERAPEUTICS

The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status

(2010) Jenny C. NGAI et al.   RESPIROLOGY